Media & News
Learn more about our work in the biopharmaceutical contract manufacturing business by checking out our latest news, videos and information material.
Whitepaper
Learn more about hot topics in the biopharmaceutical contract manufacturing business.
Learn more about hot topics in the biopharmaceutical contract manufacturing business.
Whitepaper
Learn more about the winner of the honorable mention FOYA 2020 award.
Whitepaper
Learn more about our strong experience in perfusion and fully continuous manufacturing of biopharmaceuticals at our site in Fremont, CA.
Whitepaper
The biopharmaceutical contract manufacturing chain of Boehringer Ingelheim includes the aseptic production of various dosage forms of finished drug products in liquid and lyophilized vials or pre-filled syringes.
Whitepaper
Pioneering CMO in China by leading the CMO trial with the authorities and bringing over 30 years of experience to China to better serve patients and the biopharmaceutical industry.
Whitepaper
Boehringer Ingelheim has developed and continuously improved the production process for plasmid DNA.
Whitepaper
Interaction and collaboration with customers when transferring processes from a customer to one of Boehringer Ingelheim´s manufacturing sites.
Whitepaper
A fully automated microbial cultivation platform is established at Boehringer Ingelheim Regional Center Vienna (RCV) to serve the need for scalable high-throughput early-stage microbial bioprocess development.
Case Study
Während biopharmazeutische Prozesse bisher nur durch aufwändige, zeitintensive Analysenmethoden und im Rückblick beurteilt werden konnten, ermöglicht ein neu entwickeltes Verfahren die Kontrolle dieser Prozesse erstmals in Echtzeit.
Research Article
The authors present a model for predicting mixing behavior in a tortuous‐flow‐path reactor. This developed model allows fine‐tuning of flow rate and chamber volume based on process requirements.
Research Article
The authors present an alternative, novel, linked bioreactor process that might serve to reduce manufacturing costs and increase process productivity potentially helping to meet the high projected demands of biologics and competition from biosimilars.
Research Article
Among production cell lines for recombinant biopharmaceuticals, Chinese hamster ovary (CHO) cells are the most commonly used production hosts due to beneficial characteristics such as high productivity, robustness, human‐like post‐translational modifications and ease of genetic modification.
Research Article
The creation of a fully automated microbial cultivation platform for microbial process development that allows “hands‐off” operation without any manual intervention.
Press Releases
Read the latest press releases about Boehringer Ingelheim BioXcellence™
Read the latest press releases about Boehringer Ingelheim BioXcellence™
30.12.2019
Videos
Check out the comprehensive collection of videos from Boehringer Ingelheim BioXcellence™.
For further videos, please visit our YouTube channel.
Check out the comprehensive collection of videos from Boehringer Ingelheim BioXcellence™.
For further videos, please visit our YouTube channel.
Biopharmaceuticals - Competence and Experience for Medicines of the Future
Over 35 years ago, Boehringer Ingelheim started developing and producing biopharmaceuticals as one of the first companies worldwide. Biopharmaceuticals are produced by using either mammalian cell cultures or microorganisms such as bacteria or yeast.
Introducing Boehringer Ingelheim BioXcellence™
Boehringer Ingelheim BioXcellence™ offers reliable biopharmaceutical contract development and manufacturing business to the pharmaceutical and biotechnology industry, providing the entire lifecycle chain from DNA to Fill & Finish around the globe.
Producing Value with Boehringer Ingelheim BioXcellence™
Boehringer Ingelheim BioXcellence™ offers over 35 years of biotechnology experience and a global network providing the entire production chain from DNA to Fill & Finish.
World‘s leading and most trusted partner
Boehringer Ingelheim BioXcellence™ is the preferred partner for contract manufacturing of biopharmaceutical medicines through the entire product lifecycle from DNA to Fill & Finish.
Leader in aseptic processing of biopharmaceutical medicines – Liquid Vials
Boehringer Ingelheim BioXcellence™ offers filling services of liquid preparations in vials for clinical or commercial supply. To accommodate your needs, we offer flexible vial and batch sizes from 1,000 to 25,000 units.
Leader in aseptic processing of biopharmaceutical medicines – Freeze-dried Vials
Boehringer Ingelheim BioXcellence™ offers filling services of freeze-dried preparations in vials for clinical or commercial supply. To accommodate your needs, we offer flexible vial and batch sizes from 1,000 to 25,000 units.
Mammalian Manufacturing Plant Shanghai, China
Boehringer Ingelheim is the first multi-national pharmaceutical company bringing over 35 years of experience to China, to better serve the patients and the biopharmaceutical industry.
Transparent production process
Full scale 15,000 L acrylic reactor model enables us to better understand bioreactor behaviour, optimize process parameters and verify numerical flow simulations.
Boehringer Ingelheim BioXcellence™ Site Expansion in Fremont, California
Journey of our significant site expansion of our biopharmaceutical development and manufacturing facility in Fremont, CA, USA.
Information Brochures
Click on the links below to download information material from Boehringer Ingelheim BioXcellence™.
Click on the links below to download information material from Boehringer Ingelheim BioXcellence™.
Contract manufacuring business of Boehringer Ingelheim BioXcellence™
Boehringer Ingelheim BioXcellence™ offers services from DNA to Fill & Finish, from clinical to commercial supply.
Wherever you are, we are by your side.
From our global network we offer first class biopharmaceutical medicines anywhere in the world.
Integrated and powerful contract manufacturing services in Shanghai, China
As the first multi-national pharmaceutical company Boehringer Ingelheim BioXcellence™ established the contract manufacturing business of biopharmaceuticals to in Shanghai.
Fill & Finish services for vials & syringes
From formulation and filling to visual inspection – with our more than 30 years of experience producing more than 25 million units per year, we tailor our products and services to the needs of our customers.